|
|
Volumn 27, Issue 5, 2015, Pages 751-753
|
|
Liraglutide-related cholelithiasis
a
|
|
Author keywords
Cholelithiasis; Liraglutide; Ursodeoxycholic acid
|
|
Indexed keywords
CEFTRIAXONE;
INFUSION FLUID;
LIRAGLUTIDE;
URSODEOXYCHOLIC ACID;
ANTIDIABETIC AGENT;
CHOLAGOGUE;
GLUCAGON LIKE PEPTIDE 1;
ABDOMINAL PAIN;
ACUTE CHOLECYSTITIS;
AGED;
ARTICLE;
CASE REPORT;
CHOLELITHIASIS;
DISEASE DURATION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
ECHOGRAPHY;
EMERGENCY CARE;
FEMALE;
FLUID THERAPY;
FOLLOW UP;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REMISSION;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ANALOGS AND DERIVATIVES;
CHEMICALLY INDUCED;
DIABETES MELLITUS, TYPE 2;
PATHOPHYSIOLOGY;
TREATMENT WITHDRAWAL;
AGED;
CHOLAGOGUES AND CHOLERETICS;
CHOLELITHIASIS;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
HYPOGLYCEMIC AGENTS;
LIRAGLUTIDE;
TREATMENT OUTCOME;
URSODEOXYCHOLIC ACID;
WITHHOLDING TREATMENT;
|
|
EID: 84941362174
PISSN: 15940667
EISSN: 17208319
Source Type: Journal
DOI: 10.1007/s40520-015-0335-2 Document Type: Article |
|
Times cited : (7)
|
|
References (5)
|
